You are here: Industry Insights > approval

News List

FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder worldpharmanews
February 11, 2019
The U.S. Food and Drug Administration (FDA) today approved Cablivi (caplacizumab-yhdp) injection
FDA approves first generic Advair Diskus worldpharmanews
February 01, 2019
The U.S. Food and Drug Administration approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in...
European approval for paediatric cystic fibrosis drug europeanpharmaceuticalreview
January 24, 2019
A paediatric treatment for 2 to 5 year olds has been approved by the European Commission to treat children with the most common form of cystic fibrosis…
Looking back 2018-Review and Analysis of Approval Data of Imported Pharmaceutical Products PharmaSources/zhulikou431
January 23, 2019
2018 can be said to be a year where profound changes happened to the Chinese pharmaceutical industry...
Teva Announces FDA Approval of Digital Inhaler with Built-In Sensors americanpharmaceuticalreview
January 11, 2019
Teva Pharmaceutical announced the U.S. Food and Drug Administration (FDA) has approved ProAir Digihaler (albuterol sulfate 117 mcg) inhalation powder, the first and only digital inhaler with built-in sensors which ....
Daiichi Sankyo receives Japanese marketing approval for two drugs pharmaceutical-technology
January 10, 2019
Daiichi Sankyo has obtained marketing approval in Japan for its minnebro and tarlige tablets to treat hypertension and peripheral neuropathic pain (PNP) respectively.
Lupin gets US FDA nod for generic schizophrenia drug expressbpd
January 08, 2019
The drug is a generic version os Sunovion Pharmaceuticals’ Latuda tablets
Lupin receives US FDA approval for Clobazam tabs expressbpd
December 18, 2018
The drug is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients two years of age or older
FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder worldpharmanews
December 03, 2018
This is the first FDA approval of a treatment for LEMS.
EU OKs Mundipharma’s Neulasta biosimilar contractpharma
November 28, 2018
The Mundipharma network of independent associated companies says European regulators have approved use of Pelmeg, a biosimilar of Amgen’s white blood cell booster Neulasta.

Previous page 1 2 3 4 5 6 7 Next page